May 15 - 17, 2025 Brasilia - Brazil

Mini Meeting Tolmar

12 pm – 2 pm

MINI MEETING TOLMAR

GUESTS ONLY

12 pm – 1 pm

Lunch

1 pm – 2 pm

OVELIA – A Global Phase 3 Trial of Ovarian Functional Suppression utilizing a novel 3-month formulation of leuprolide acetate

  • Tolmar – Company Overivew
  • GnRH therapies and use in pre-menopausal patients
  • SOFT/TEXT: Considering study results in the context of patient care
  • Overview of the OVELIA clinical trial
  • Q&A